1)大腸癌研究会(編):大腸癌取扱い規約,第8版,金原出版,2013
2)Kitajima K, et al:Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma;A Japanese collaborative study. J Gastroenterol 39:534-543, 2004
3)大腸癌研究会(編):大腸癌治療ガイドライン,医師用2016年版,金原出版,2016
4)Ohtani H, et al:A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for colorectal cancer. J Cancer 2:425-434, 2011
5)Kitano S, et al:Survival outcomes following laparoscopic versus open D3 dissection for stage Ⅱ or Ⅲ colon cancer(JCOG0404);A phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol 2:261-268, 2017
6)Ueno H, et al:Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 127:385-394, 2004
7)Andre T, et al:Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage Ⅱ or Ⅲ colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116, 2009